<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940928-0-00031</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <CFRNO>21 CFR Part 310</CFRNO> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[Docket No. 77N&hyph;0094]</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=91 g=1 f=1 -->  <RINDOCK>RIN 0905&hyph;AA06</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Drug Products for the Treatment and/or Prevention of Nocturnal Leg Muscle Cramps for Over-The-Counter Human Use; Correction <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Final rule; correction. <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The Food and Drug Administration (FDA) is correcting a final rule that appeared in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  of August 22, 1994 (59 FR 43234). The document established that any over-the-counter (OTC) drug product for the treatment and/or prevention of nocturnal leg muscle cramps is not generally recognized as safe and effective and is misbranded. The document was published with some typographical errors. This document corrects those errors.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> LaJuana D. Caldwell, Office of Policy (HF&hyph;27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;2994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In FR Doc. 94&hyph;20449, appearing on page 43234, the following corrections are made:  <!-- PJG 0012 frnewline --> 1. On page 43239, in the third column, in reference 3, line 5, and in reference 4, line 2, the word ``Q&hyph;VELR'' is corrected to read ``Q&hyph;VEL <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=6 f=2 --> &reg; <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ''.  <!-- PJG 0012 frnewline --> 2. On page 43242, in the second column, line 21, and in the first full paragraph, line 19, the number ``106'' is corrected to read ``10 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 6 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ''. <!-- PJG 0012 frnewline --> 3. On page 43245, in the second column, in reference 4, line 2, and in reference 5, line 4, the word ``Q&hyph;VELR'' is corrected to read ``Q&hyph;VEL <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=6 f=2 --> &reg; <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ''. <!-- PJG 0012 frnewline --> 4. On page 43249, in the second column, in reference 1, line 2, and in reference 2, line 4, the word ``Q&hyph;VELR'' is corrected to read ``Q&hyph;VEL <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=6 f=2 --> &reg; <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ''. <!-- PJG 0012 frnewline --> 5. On page 43250, in the third column, in reference 1, line 2, and in reference 2, line 4, the word ``Q&hyph;VELR'' is corrected to read ``Q&hyph;VEL <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=6 f=2 --> &reg; <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> ''. <!-- PJG 0012 frnewline --> 6. On page 43252, in the first column, in the second paragraph, in line 2, ``regulatuion'' is corrected to read ``regulation''; and in line 7, the word ``agencies'' is corrected to read ``agency's''; and in line 8, the word ``substances'' is corrected to read ``substance''. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: September 21, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FURTHER> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> William K. Hubbard, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Interim Deputy Commissioner for Policy. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;24014 Filed 9&hyph;27&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            